A 30-Month-Old Child Diagnosed With Moderate Croup: First-Line Medications, Mechanisms, and Evidence

First-line medication for a 30-month-old with moderate croup is a single dose of oral dexamethasone (0.15–0.6 mg/kg; commonly 0.15–0.6 mg/kg once, with many protocols using 0.6 mg/kg as a maximum single dose). Nebulized budesonide is the alternative when vomiting or severe distress prevents oral dosing. Add nebulized epinephrine only if stridor persists at rest or there is increased work of breathing. Moderate croup is defined by persistent stridor at rest, suprasternal and intercostal retractions, and some agitation, without hypoxia or fatigue.

What "moderate croup" actually means at the bedside

Croup is laryngeal and subglottic inflammation, most often from parainfluenza virus, and severity is graded by stridor, retractions, air entry, and mental status. The standard Westley score assigns points across five domains; a score of 3–5 generally corresponds to moderate disease, 6–11 to severe, and 12 or more to impending respiratory failure. A 30-month-old sits squarely in the peak age band for croup, which is roughly 6 months to 3 years.

The clinical distinction that drives medication choice is not the presence of stridor but whether that stridor occurs at rest and whether retractions are visible. Stridor only with agitation or crying is mild. Stridor at rest with clear retractions is moderate. Hypoxia, fatigue, or decreasing stridor as the child tires signals severe disease and a different escalation path.

The first-line pediatric society recommendation is a single dose of a corticosteroid, with dexamethasone preferred because of its long half-life and once-daily convenience. The mechanism is the reason this works so reliably: corticosteroids reduce capillary permeability and mucosal edema in the subglottic airway, the narrowest and least distensible segment in this age group.

Mechanism: why a steroid changes a 1 mm problem

The subglottis in a toddler is a small ring, and airway resistance scales inversely with the fourth power of radius (Poiseuille's law). Because the radius is already small, even 1 mm of circumferential edema can dramatically raise resistance. This is why croup can look mild at noon and moderate by evening.

Dexamethasone binds the glucocorticoid receptor and suppresses transcription of pro-inflammatory cytokines, reduces vascular endothelial permeability, and limits leukocyte migration into the airway wall. Edema decreases over hours rather than minutes, which is why the clinical improvement after a single dose is often described as gradual and sustained rather than immediate.

Nebulized budesonide acts more locally and has been used as an alternative, particularly when oral administration would likely fail because of vomiting or combative distress. Its onset is also measured in hours. Neither steroid produces bronchodilation; they treat the edema, not the bronchospasm, which is why epinephrine occupies a separate role.

Epinephrine works by alpha-adrenergic vasoconstriction in the airway mucosa, reducing edema and mucosal blood flow within minutes. Its effect is temporally limited, typically 1–2 hours, and a child who improves and then worsens after that window may be rebounding. This is the professional caveat: improvement after epinephrine is not proof that the child is safe to discharge without observation.

Plain language: the steroid shrinks the swelling over hours, while the epinephrine buys time by squeezing the swelling down for a short while.

Quantified context: doses, timing, and the numbers that matter

A common dexamethasone regimen for moderate croup is 0.6 mg/kg once orally, with many protocols capping the dose or using 0.15 mg/kg as the low end of an equivalent range. The 0.15 mg/kg and 0.6 mg/kg doses have been compared in trials and both are used; the higher dose is favored in some protocols for moderate-to-severe disease. Because the exact regimen depends on local protocol and clinical context, this article describes ranges rather than a prescription.

Nebulized budesonide is often given as 2 mg in 2–4 mL of saline, once. Its use is typically reserved for children who cannot take oral medication or as an adjunct.

Nebulized epinephrine is commonly dosed as 0.5 mL of 2.25% racemic epinephrine diluted in saline, or 5 mL of 1:1000 epinephrine, delivered by nebulizer with oxygen. These are the two standard concentration approaches; the agent is a temporizing measure, not a definitive treatment.

Timing matters as much as dosing. Steroid effect generally appears within 1–2 hours and peaks over several hours. Epinephrine onset is within minutes and wears off within roughly 1–2 hours. That mismatch explains why a child treated with both in an urgent care setting should be observed long enough to confirm the steroid is carrying the improvement.

Timeline: what happens after first-line treatment

The observation window is the practical reason the timeline table matters. A child who receives epinephrine and looks better at 30 minutes has not yet demonstrated that the underlying edema is controlled.

Edge cases that change the first-line plan

Age is one edge case, but a 30-month-old is not at the extremes. Children younger than 6 months and older than 6 years can still develop croup, but atypical features become more likely and the differential should broaden.

Vomiting is the most common practical barrier to oral dexamethasone. In that situation, nebulized budesonide is the accepted alternative, and clinicians often avoid repeated oral attempts that worsen distress.

Suspected bacterial tracheitis or epiglottitis is a different disease. High fever, toxic appearance, drooling, and rapid progression should redirect evaluation away from simple croup management. These are the cases where a steroid alone is the wrong answer.

Immunocompromise, recent airway instrumentation, or known structural airway anomalies warrant a lower threshold for specialist involvement and a careful review of whether the diagnosis is truly viral croup.

Clinical caveat to reconcile: some protocols use the Westley score only for research, while bedside decisions use stridor at rest, retractions, and air entry. The thresholds are complementary, not interchangeable. A numerical score does not replace serial clinical observation.

Misconceptions worth correcting

First, croup is not treated with antibiotics. The overwhelming majority of cases are viral, and antibiotics add risk without benefit.

Second, a "barky cough" alone does not equal moderate croup. The moderate label requires resting stridor and retractions, which is what justifies systemic steroid plus consideration of epinephrine.

Third, humidified air and steam are widely used at home but are not first-line medications and have weak evidence. They can be comforting but should not delay medical evaluation in moderate disease.

Fourth, epinephrine is not the first-line medication. It is a bridging therapy for moderate-to-severe disease with resting stridor or increased work of breathing, and it does not replace steroid.

Fifth, a single dose of dexamethasone is often enough. Repeated steroid dosing is not routine and adds little in uncomplicated cases.

Plain language: the steroid is the treatment; the epinephrine is the rescue bridge; the antibiotics are usually irrelevant.

Practical actions and red-flag thresholds

Give a single dose of oral dexamethasone if the child can swallow without distress, using the dose range specified by the treating clinician or local protocol. Choose nebulized budesonide if vomiting, combativeness, or oral refusal makes dexamethasone impractical. Reserve nebulized epinephrine for stridor at rest with retractions, increased work of breathing, or hypoxia, and observe for at least 1–2 hours afterward. Seek emergency care for drooling, inability to swallow, tripod positioning, cyanosis, decreasing stridor with fatigue, or altered mental status. Reassess at 2–4 hours if treated in an acute setting; persistent resting stridor after that window may require further evaluation. Do not give over-the-counter cough suppressants or antibiotics for typical viral croup.

The red flags are the part families most often miss: drooling and difficulty swallowing point away from croup toward epiglottitis or a foreign body, and decreasing stridor in a tiring child is not improvement.

Limitations and what this cannot tell you

This article describes general mechanisms and ranges, not a prescription for a specific child. Doses vary by protocol, weight, and clinical setting, and the treating clinician must choose the agent and route based on the examination.

The evidence base for low-dose versus high-dose dexamethasone is not perfectly settled, and local formularies differ. The comparison of oral versus nebulized steroid is similarly context-dependent. What is stable is the principle: corticosteroid first, epinephrine as a bridge when resting stridor or increased work of breathing is present.

For a medical emergency or if a child is struggling to breathe, contact local emergency services immediately. This article is general educational information, not a diagnosis or treatment plan, and it does not promise any outcome; consult a qualified local clinician for care specific to the child.